Valuation (41%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 22.61 | -32.94 |
PEG Ratio (TTM) | 0.23 | -2.90 |
P/S Ratio (TTM) | N/A | 50.30 |
P/B Ratio (TTM) | 0.89 | 6.94 |
P/FCF Ratio (TTM) | -929.62 | -209.89 |
Price to 5YR AVG Earnings Ratio | N/A | -29.45 |
Price to 5YR AVG FCF Ratio | -2.48 | -26.95 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.18% | 48.68% |
ROE (TTM) | 2.93% | -546.16% |
Net Profit Margin (TTM) | N/A | -357.17% |
ROIC 5YR AVG | -0.18% | 831.74% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 706.36% | -1.16% | 2,000.24% |
Revenue | -4.42% | -33.33% | -40.00% |
Net Income | 729.05% | -24,420.18% | -14,537.00% |
Cash Flow | -2,172.07% | 180,572,970.87% | 108,343,767.76% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.06 | 4.84 |
Quick Ratio (TTM) | 0.06 | 24.36 |
D/E Ratio (TTM) | 0.10 | 0.25 |
Interest Coverage (TTM) | -5.97 | 3.72 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 2.76 | 21.88 |
LTL to 5YR AVG FCF | -8.18 | -1.27 |
Shares Outstanding Growth 5YR AVG | 1,120.97% | 515.59% |